Johnson & Johnson CDR (JNJ0)
XDUS
Real-time Data
06:00 AM
Day's Range
20.2052 wk Range
13.50Overview - JNJ0 - Johnson & Johnson CDR
Key Statistics
Valuation
Enterprise Value
28.22B
P/E (Trailing)
‪19.40‬
PEG Ratio
‪-169.53‬
Price / Book
‪6.12‬
EV / EBITDA
‪0.80‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪67.87%‬
Operating Margin
‪35.62%‬
Return on Assets
‪13.45%‬
Return on Equity
‪32.87%‬
Ownership
Shares Outstanding
2.40B
Price stats
50-Day Avg
‪19.81‬
200-Day Avg
‪18.32‬
Dividends
Frequency
Quarterly
Peers - JNJ0 - Johnson & Johnson CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- JNJ0XDUSJohnson & Johnson CDR+32.38%52-week change19.41P/E (Trailing)‪67.87%‬Profit Margin
- LLYXDUSEli Lilly and Company+43.08%52-week change46.79P/E (Trailing)‪83.04%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+42.50%52-week change-13.04P/E (Trailing)‪58.75%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+41.66%52-week change17.34P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+35.99%52-week change21.13P/E (Trailing)‪75.69%‬Profit Margin
- JNJXDUSJohnson & Johnson+33.33%52-week change20.82P/E (Trailing)‪67.87%‬Profit Margin
- 7XPXDUSOrganon & Co.+31.76%52-week change16.18P/E (Trailing)‪53.29%‬Profit Margin
Profile Summary - JNJ0 - Johnson & Johnson CDR
About
Johnson & Johnson CDR represents a Canadian Depositary Receipt of Johnson & Johnson, providing Canadian investors access to this global healthcare conglomerate through the Toronto Stock Exchange. Johnson & Johnson is renowned for its extensive portfolio in consumer health, pharmaceuticals, and medical devices. By…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
